Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Quantum Clovera Investama Tbk's earnings per share without non-recurring items for the
three
months ended in Mar. 2026 was Rp-1.77.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was Rp-8.67.
During the past 3 years, the average earnings per share (NRI) Growth Rate was -4.50% per year.
During the past 5 years, the average earnings per share (NRI) Growth Rate was 30.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for PT Quantum Clovera Investama Tbk's EPS without NRI or its related term are showing as below:
ISX:KREN'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -26.2 Med: 43.5 Max: 115.4
Current: -4.5
During the past 13 years, PT Quantum Clovera Investama Tbk's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 115.40% per year. The lowest was -26.20% per year. And the median was 43.50% per year.
ISX:KREN's 3-Year EPS without NRI Growth Rate is ranked worse than 67.23% of 827
companies
in the Asset Management industry
Industry Median: 12.3
vs ISX:KREN: -4.50
PT Quantum Clovera Investama Tbk (ISX:KREN) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
PT Quantum Clovera Investama Tbk EPS without NRI Related Terms
PT Quantum Clovera Investama Tbk EPS without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Quantum Clovera Investama Tbk EPS without NRI Chart
ISX:KREN vs BLK, BX, KKR: EPS without NRI Comparison
For the Asset Management subindustry, PT Quantum Clovera Investama Tbk's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Quantum Clovera Investama Tbk PE Ratio without NRI vs Asset Management Industry
For the Asset Management industry and Financial Services sector, PT Quantum Clovera Investama Tbk's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where PT Quantum Clovera Investama Tbk's PE Ratio without NRI falls into.
PT Quantum Clovera Investama Tbk EPS without NRI Calculation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp-8.67
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Quantum Clovera Investama Tbk (ISX:KREN) has a EPS without NRI of Rp-8.67 as of Mar. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on PT Quantum Clovera Investama Tbk and its competitors. According to the industry distribution chart, PT Quantum Clovera Investama Tbk ranks #556 out of 827 companies in the Asset Management industry, placing it in the top 67.2%.
Is PT Quantum Clovera Investama Tbk's EPS without NRI too high?
PT Quantum Clovera Investama Tbk's current EPS without NRI is Rp-8.67. Based on the distribution chart, PT Quantum Clovera Investama Tbk ranks #556 out of 827 companies in the Asset Management industry, which is below the industry midpoint. Overall, PT Quantum Clovera Investama Tbk has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Quantum Clovera Investama Tbk's EPS without NRI compare to BLK and BX?
According to the Asset Management industry distribution chart, PT Quantum Clovera Investama Tbk ranks #556 out of 827 companies for EPS without NRI. This places PT Quantum Clovera Investama Tbk in the lower half of its industry. The industry median EPS without NRI is 12.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for an Asset Management company?
The median EPS without NRI among Asset Management companies is 12.30, based on 827 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on PT Quantum Clovera Investama Tbk and its competitors. For the Asset Management industry, the median EPS without NRI is 12.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Quantum Clovera Investama Tbk's current EPS without NRI is Rp-8.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Quantum Clovera Investama Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Quantum Clovera Investama Tbk (ISX:KREN) is currently considered Fairly Valued. The stock's GF Value™ is Rp12.07, compared to a current price of Rp13.00 — trading 7.7% above its estimated fair value. The current EPS without NRI is Rp-8.67. PT Quantum Clovera Investama Tbk's overall GF Score™ is 51/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For PT Quantum Clovera Investama Tbk (ISX:KREN), the current EPS without NRI is Rp-8.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Quantum Clovera Investama Tbk (ISX:KREN) Overvalued in 2026?
Based on GuruFocus' analysis, PT Quantum Clovera Investama Tbk stock appears to be overvalued.
The current stock price of Rp13.00 is trading 7.7% above its estimated GF Value™ of Rp12.07.
GuruFocus considers PT Quantum Clovera Investama Tbk to be Fairly Valued.
Key valuation signals for ISX:KREN:
EPS without NRI: Rp-8.67
GF Value™: Rp12.07 vs. price of Rp13.00 (7.7% above fair value)
No single metric tells the full story. See the ISX:KREN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Quantum Clovera Investama Tbk is a digital business integrator that focuses on investment in diversified and new economic sectors. Through its subsidiaries, the company is involved in various business fields, including the sale of digital products and services, digital product aggregation, cloud-based advertising, software-as-aservice (SaaS), the provision of clean energy products and services, digital wholesale, as well as content and entertainment. Its segment comprises: Financial and Investment, and Technology and Digital segments. The majority of revenue is derived from the Technology and Digital segment.
51GF Score
Get the complete analysis for ISX:KREN
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KREN has been successfully added to your 
